Cancer

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.

(iStock image)

Patients with clonal hematopoiesis have increased heart disease risk following cancer treatment 

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.

(iStock image)

Study identifies potential target for blood cancer treatment, prevention

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.

Lucy Spalluto and Jennifer Lewis awarded $1 million lung cancer screening grant

Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.

Anna Means, PhD, R. Daniel Beauchamp, MD, and colleagues are studying a group of proteins that are essential to the growth of colorectal cancer tumors.

Vanderbilt research community mourns loss of longtime colleague Anna Means

In addition to her research, Dr. Means mentored dozens of undergraduate, graduate and postdoctoral students, research staff and faculty.

(iStock image)

Interim data reported for multiple myeloma off-the-shelf CAR-T therapy  

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.

1 2 3 72